Zobrazeno 1 - 10
of 31 084
pro vyhledávání: ''
Publikováno v:
Expert opinion on biological therapy. 22(8)
Introduction There are more than two dozen bispecific antibodies (BsAbs) in development with a variety of designs which are relevant to breast cancer. The field of BsAbs for breast cancer includes agents that co-direct immune recognition of the cance
Publikováno v:
BMJ Case Rep
Breast cancer is the most common cancer among women in the USA and rarely metastasises to the gastric wall. We present a case of a 69-year-old woman with medical history of stage II-B breast cancer who presented with epigastric abdominal pain and bla
Publikováno v:
BMJ Case Rep
A 40-year-old woman was referred to the Breast Unit with a solid lump in her right breast. Investigations revealed an invasive lobular carcinoma. The patient underwent a right-sided mastectomy and sentinel lymph node (LN) biopsy, which confirmed axil
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:624-635
Objective: To investigate the effect of miR-146a on the sensitivity of breast cancer cells to paclitaxel (PTX). Materials and Methods: The mRNA expressions of miR-146a in normal breast cancer cells...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:662-672
Background: Long non-coding RNA actin filament-associated protein1-antisense RNA 1 (AFAP1-AS1) was confirmed to be associated with tumorigenesis. However, the role of AFAP1-AS1 in breast cancer was...
Long Noncoding RNA NEAT1 Promotes the Progression of Breast Cancer by Regulating miR-138-5p/ZFX Axis
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:636-649
Background: Growing evidence demonstrated that long noncoding RNAs (lncRNAs) were involved in the progression of diverse cancers, including breast cancer (BC). Recent studies indicated that lncRNA ...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:650-661
Background: Breast cancer is one of the most prevalent cancers that often occur in females. Long noncoding RNA differentiation antagonizing nonprotein coding RNA (DANCR) has been involved in the pathogenesis of various tumors, including breast cancer
Autor:
Ken Kato, Akihiro Sato, Toshihiko Doi, Masashi Wakabayashi, Atsushi Ohtsu, Hiroki Hara, Shunji Takahashi, Takashi Kojima, Tomohiro Nishina, Shogo Nomura, Kei Muro
Publikováno v:
Esophagus. 19:702-710
4069 Background: BKM120 is an oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, which showed promising activity in breast cancer and squamous cell carcinoma of head and neck. We prospectively investigated clinical activity, safety and
Publikováno v:
Seminars in Cancer Biology. 81:241-258
The present review has analyzed the scientific literature, available in the PubMed and Scopus databases, in order to summarize the current state of diet anthocyanin research in breast cancer (BC) and colorectal cancer (CRC) animal models but also for
Autor:
Hongxin Su, Fei Su, Hui Yang, Yana Bai, Yi Xiao, Yongbin Lu, Tao Zhang, Xiao-Ling Ling, Xiaobin Zhang
Publikováno v:
Cancer Biomarkers. 33:57-70
BACKGROUND: Triple-negative breast cancer (TNBC) is a highly malignant breast cancer subtype with a poor prognosis. The cell cycle regulator cyclin A2 (CCNA2) plays a role in tumor development. Herein, we explored the role of CCNA2 in TNBC. METHODS: